PainScript Named “Best Chronic Care Management Platform” and Recognized with the “Pain Care Excellence Award 2021” by Global Health and Pharma Magazine

GHP Magazine’s 2021 Technology Awards Highlight Innovations that Improve Healthcare and Quality of Life

New York, NY – February 15, 2022 – PainScript, Inc., a telehealth and compliance technologies (TACT) company offering a flexible personalized telehealth platform for chronic care management, and a subsidiary of Optimus Healthcare Services, Inc. (OTC: OHCS), announced today that it was named the “Best Chronic Care Management Platform” and received the “Pain Care Excellence Award 2021” as part of the Global Health and Pharma (GHP) Magazine’s 2021 Technology Awards.  The GHP Technology Awards recognize businesses and professionals who have made exceptional contributions and innovations in the medical technology industry.

The PainScript application is an easy-to-use mobile app that connects physicians with their patients in an individualized manner designed to improve medication compliance and care plan adherence.  Validated through nine peer-reviewed and published trials, and through the use of daily “touches,” the PainScript TACT solution provides physicians and patients with early warning signs of deteriorating health, while proactively increasing compliance with therapeutic protocols.  Initial verticals include chronic pain patients under the care of a pain management specialist and substance use disorder (SUD) patients under psychiatric care. A bariatric vertical is in near-term development with a target launch in the first half of 2022, and additional care verticals are planned for late 2022 and into 2023.

“The PainScript solution represents the cutting edge of the Optimus TACT approach that is designed to improve health outcomes for patients with chronic conditions requiring daily medication and on-going care plan management,” said Dan Cohen, CEO of PainScript and President of Optimus Healthcare Services. “PainScript allows doctors to put patients first with a user-friendly app that receives patient provided answers to key clinically validated questions daily to gauge and improve care plan and medication adherence.  In doing so, PainScript leads to better outcomes for patients and the physicians that treat them.”

Mr. Cohen continued: “We are honored to be both named the “Best Chronic Care Management Platform” and receive the “Pain Care Excellence Award 2021” by GHP Magazine as part of its 2021 Technology Awards. We express our gratitude to the awards’ committee for recognizing PainScript as an innovative business and medical technology dedicated to improving patient care and the healthcare industry as a whole.”  

About PainScript, Inc.

PainScript, a subsidiary of Optimus Healthcare Services, Inc. (OTC: OHCS), is a telehealth and compliance technologies (TACT) company offering a personalized, flexible telehealth platform for physicians and their patients who require improved care plan management and medication adherence within different chronic care conditions.  For more information on PainScript, please visit our website at https://www.painscript.com/.

About Optimus Healthcare Services, Inc.

Optimus Healthcare Services, Inc. is focused on creating a network of innovative healthcare companies that advance clinical research, disease management and improve physician/patient interactions.  Optimus accomplishes this by acquiring a controlling interest in a variety of healthcare-related businesses and then enhances the attributes of its portfolio companies by improving the operational, technological, managerial and financial capabilities of each company.  Optimus’s portfolio of companies includes, PainScript, a solution provider in its Telehealth and Compliance Technology (TACT) division, Clinical Research Alliance, a research services provider focused on bringing state-of-the-art clinical trial capabilities to community-based physicians, hospitals and their patients, and VaccinationsRx, a boutique concierge vaccination pharmacy dedicated to simplifying access to vaccines.  For more information on Optimus, please visit our website at https://www.optimushealthcare.com/.

Caution Concerning Forward Looking Statements:

This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not a guarantee of future actions or performance. These forward-looking statements are based on information currently available to Optimus Healthcare and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning Optimus Healthcare’s business are described in Reports filed with the OTCIQ.  Optimus Healthcare is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Dan Cohen
Chief Executive Officer, PainScript
President, Optimus Healthcare Services
dlc@painscript.com
202-329-1825

Investors/Media:
Tiberend Strategic Advisors, Inc.
Jason Rando/Maureen McEnroe, CFA
(212) 375-2665 / 2664
jrando@tiberend.com
mmcenroe@tiberend.com